ClinicalTrials.Veeva

Menu

Patterns and Outcomes of Peripheral Vascular Complications Following Self-injection of Addictive Drugs.

A

Assiut University

Status

Not yet enrolling

Conditions

IVDA

Study type

Observational

Funder types

Other

Identifiers

NCT06579638
IVDA Complications

Details and patient eligibility

About

Intravascular drug abuse is a common health problem with increasing prevalence throughout the world. The estimated number of IV drug abusers around the world is15.6 millions.

Full description

Intravascular drug abuse is a common health problem with increasing prevalence throughout the world. The estimated number of IV drug abusers around the world is15.6 millions.The prevalence of injected drug use is estimated between 0.09% and 1.3% depending on geographic location. There are various complications of IV drug abuse that are related to the toxicity of the substance, mode of consumption, and drug taking mode. These complications include skin and soft tissue infection (cellulitis, abscess, necrotizing fasciitis) (28%),infected(ranges from .03% to 1%)or non-infected pseudoaneurysm ,arterial ischemia( thrombosis , distal embolization), and venous thrombosis(29%).

The wide spectrum of complications due to IVDA mandates a wide range of treatment for each type starting from simple medical treatment such as antibiotics or anticoagulation to the most extensive surgical treatment options in cases such as PA that may require ligation of the arterial supply without revascularization. This may lead to gravid complications such as limb amputation.

Enrollment

100 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Current IV drug abuser
  • (Age from 18 to 80 )
  • Presented with peripheral vascular complications (pseudoaneurysm, limb ischemia, venous thrombosis, skin infection.)

Exclusion criteria

  • Drug intake other than IV
  • ( less than 18 or more than 80 )
  • Presented with overdose
  • Malignancy or serious illness
  • Causes of vascular complications other than IV drug abuse

Trial contacts and locations

0

Loading...

Central trial contact

Islam M Hassan, Resident

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems